Markets.com Logo

9MDA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    25.5944$
  • Previous Close
    25.5944$
  • 52 Week Change
    28.50$
  • Day Range
    0.00$
  • 52 Week High/Low
    23$ - 51.5$
  • Dividend Per Share
    --
  • Market cap
    76 051 M$
  • EPS
    --
  • Beta
    0.344
  • Volume
    --

About

The stock financial product symbol 9MDA.F refers to the share of MorphoSys AG, traded on the Frankfurt Stock Exchange (FSE). MorphoSys AG is a German biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic antibodies for various diseases.

Fed's New Era: Warsh Signals Caution Amid Inflation and Market Jitters

Emma Rose|--

Storage Chip Sector Rebound: Is AI Sustaining the Cycle?

Sophia Claire|--

New Fed Chair Kevin Warsh: Reshaping Communication and Steering Market Expectations

Emma Rose|--

Goldman Sachs Revises 2027 Brent Crude Forecast to $80/bbl Amid Shifting Supply and Demand Dynamics

Sophia Claire|--

US Stock Market Volatility Surges as Trading Logic Breaks Down

Emma Rose|--

2026 World Cup: A Watershed Moment for Predictive Markets and a Boost for DraftKings

Emma Rose|--

Japanese Tungsten Hexafluoride Production Halt Disrupts Global Semiconductor Supply Chain

Sophia Claire|--

Factors

Market Sentiment: Overall investor confidence and risk appetite significantly influence stock prices. Positive sentiment drives buying, increasing demand and prices. Conversely, negative sentiment leads to selling pressure, decreasing prices. Company Performance: Key financial metrics like revenue growth, profitability, and earnings per share (EPS) directly impact stock valuation. Strong financial results typically boost investor confidence and stock prices. Industry Trends: The performance and outlook of the broader pharmaceutical and biotechnology industries affect individual stocks. Positive industry trends, such as new drug approvals or increasing healthcare spending, can benefit 9MDA.F. Economic Conditions: Macroeconomic factors like interest rates, inflation, and economic growth can indirectly influence stock prices. Strong economic conditions generally support corporate profits and investor sentiment. Regulatory Environment: Changes in regulations related to drug development, pricing, and approvals can significantly impact pharmaceutical stocks. Favorable regulatory changes may boost stock prices, while unfavorable ones can depress them. Competitive Landscape: The presence and actions of competitors in the pharmaceutical market can affect 9MDA.F's market share and profitability. Increased competition may put downward pressure on prices. News and Events: Company-specific news such as clinical trial results, product launches, and partnerships can have a significant impact on stock prices. Positive news typically leads to price increases. Investor Perception: Investor expectations and perceptions of the company's future prospects influence stock valuation. High expectations can drive up prices, while skepticism can lead to downward pressure.

People Also Watch

Latest news

Qatar's Delicate Energy Diplomacy Amidst Regional Conflict: A Balancing Act

Sophia Claire|--

Lebanon: A Geopolitical Chessboard of Iranian Influence and US Diplomacy

Emma Rose|--

Global Market Snapshot: Key Events and Analysis of Financial Markets

Liam James|--

Latest Education Articles

Most Volatile Forex Pairs: What Traders Should Know

Most Volatile Forex Pairs: What Traders Should Know

Julian Parker|--
What Happens on the Day of an IPO?

What Happens on the Day of an IPO?

Julian Parker|--
10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

10 Hot IPO Stocks to Watch in 2026: SpaceX, Anthropic, OpenAI and More

Julian Parker|--
Recommended Topics